Michelle Logan, vice president of the drug product division for Thermo Fisher Scientific, talked...
Author - David Miller
Leverage AI to Lower Cost, Barriers to Cell Therapies
Off-the-shelf cell therapies hold immense promise for revolutionizing precision medicine by...
Pharma Pulse 10/10/24: Empowering Patients in a Complex...
The latest news for pharma industry insiders.
FDA Grants Marketing Authorization for Healgen Scientific’s...
Healgen’s Rapid Check COVID-19/Flu A&B Antigen Test is the first non-prescription COVID-19/flu...
Crypto for CRISPR, a new RNAi startup, & a Nobel for AI
How does John Maraganore decide which startups to get involved in? Why are longevity-minded tech...
Study: Over 40% of Irritable Bowel Disease Patients Struggle to...
A new study found that among 2,200 patients with irritable bowel diseases, 63% encountered...
CPHI Milan 2024: New Developments in ADC Technologies
Nicolas Camper, senior director—Bioconjugation Chemistry, Abzena, discussed new advancements in...
The Role of Digital Passports in Preventing Off-Label Usage
Laura Johnson, senior director, sales, life sciences, Loftware, discusses ways that digital...
STAT+: Teva agrees to pay $450 million to settle kickback and...
In the largest settlement of its kind, Teva Pharmaceuticals agreed to pay $425 million to resolve...
Arexvy Demonstrates Sustained Protection From Respiratory...
Data from the Phase III AReSVi-006 clinical trial found that Arexvy offered a cumulative efficacy...